343 related articles for article (PubMed ID: 30069928)
1. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation biomarkers for nasopharyngeal carcinoma.
Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
[TBL] [Abstract][Full Text] [Related]
4. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
5. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analysis of aberrantly methylated-differentially expressed genes and pathways in hepatocellular carcinoma.
Sang L; Wang XM; Xu DY; Zhao WJ
World J Gastroenterol; 2018 Jun; 24(24):2605-2616. PubMed ID: 29962817
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
[TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
Shen Y; Dong S; Liu J; Zhang L; Zhang J; Zhou H; Dong W
Biomed Res Int; 2020; 2020():9710421. PubMed ID: 32337286
[TBL] [Abstract][Full Text] [Related]
9. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
[TBL] [Abstract][Full Text] [Related]
10. Identification of key DNA methylation-driven genes in prostate adenocarcinoma: an integrative analysis of TCGA methylation data.
Xu N; Wu YP; Ke ZB; Liang YC; Cai H; Su WT; Tao X; Chen SH; Zheng QS; Wei Y; Xue XY
J Transl Med; 2019 Sep; 17(1):311. PubMed ID: 31533842
[TBL] [Abstract][Full Text] [Related]
11. Identification of crucial aberrantly methylated and differentially expressed genes related to cervical cancer using an integrated bioinformatics analysis.
Ma X; Liu J; Wang H; Jiang Y; Wan Y; Xia Y; Cheng W
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32368784
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential DNA methylation biomarkers related to diagnosis in patients with bladder cancer through integrated bioinformatic analysis.
Cheng H; Liu Y; Chen G
BMC Urol; 2023 Aug; 23(1):135. PubMed ID: 37563710
[TBL] [Abstract][Full Text] [Related]
14. Identification of abnormally methylated-differentially expressed genes and pathways in osteoarthritis: a comprehensive bioinformatic study.
Zheng L; Chen W; Xian G; Pan B; Ye Y; Gu M; Ma Y; Zhang Z; Sheng P
Clin Rheumatol; 2021 Aug; 40(8):3247-3256. PubMed ID: 33420869
[TBL] [Abstract][Full Text] [Related]
15. Nine Genes Mediate the Therapeutic Effects of Iodine-131 Radiotherapy in Thyroid Carcinoma Patients.
Shuwen H; Xi Y; Miao D; Jiamin X; Jing Z; Weili G
Dis Markers; 2020; 2020():9369341. PubMed ID: 32626543
[TBL] [Abstract][Full Text] [Related]
16. Aberrantly methylated-differentially expressed genes and related pathways in cholangiocarcinoma.
Lin G; Xinhe Z; Haoyu T; Yiling L
Medicine (Baltimore); 2022 Jun; 101(25):e29379. PubMed ID: 35758372
[TBL] [Abstract][Full Text] [Related]
17. Integrated bioinformatics analysis of aberrantly-methylated differentially-expressed genes and pathways in age-related macular degeneration.
Shen Y; Li M; Liu K; Xu X; Zhu S; Wang N; Guo W; Zhao Q; Lu P; Yu F; Xu X
BMC Ophthalmol; 2020 Mar; 20(1):119. PubMed ID: 32209064
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
Liu L; He D; Wang Y; Sheng M
Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
[TBL] [Abstract][Full Text] [Related]
19. Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
Zhang Y; Fang L; Zang Y; Xu Z
Med Sci Monit; 2018 May; 24():3024-3033. PubMed ID: 29739919
[TBL] [Abstract][Full Text] [Related]
20. Identification of aberrantly methylated differentially expressed genes in age-related macular degeneration.
Xu Z; Ruan Z; Huang X; Liu Q; Li Z; Zhou X; Zhang X; Shang L
Medicine (Baltimore); 2019 Apr; 98(14):e15083. PubMed ID: 30946360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]